Literature DB >> 2983815

Evidence for neuro-effector transmission through postjunctional alpha 2-adrenoceptors in human saphenous vein.

J R Docherty, L Hyland.   

Abstract

The effects of the alpha 1-adrenoceptor antagonist prazosin and the alpha 2-adrenoceptor antagonist yohimbine were examined against stimulation-evoked contractions in human isolated saphenous veins. The concentration of yohimbine producing 30% inhibition of stimulation-evoked contractions (IC30) was 13.2 nM, whereas the IC30 of prazosin was greater than 250 nM. The inhibition of stimulation-evoked contractions by yohimbine was not prejunctionally mediated since yohimbine (0.01-0.1 microM) significantly potentiated the stimulation-evoked overflow of tritium in tissues pre-incubated with [3H]-noradrenaline. The high potency of yohimbine and the low potency of prazosin indicate that neuro-effector transmission in human saphenous vein is mediated predominantly by postjunctional alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983815      PMCID: PMC1987305          DOI: 10.1111/j.1476-5381.1985.tb12942.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

2.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Heterogeneity of post-junctional alpha-adrenoceptors in human vascular smooth muscle.

Authors:  M J Stevens; R F Moulds
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-11

4.  A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Evidence for two types of post-junctional alpha-adrenoceptor.

Authors:  J R Docherty; J C McGrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

Review 5.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

6.  Extrasynaptic location of alpha-2 and noninnervated beta-2 adrenoceptors in the vascular system of the pithed normotensive rat.

Authors:  B Wilffert; P B Timmermans; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

7.  Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated human omental arteries and veins.

Authors:  S Steen; T V Skärby; L Norgren; K E Andersson
Journal:  Acta Physiol Scand       Date:  1984-01

8.  Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.

Authors:  G M Drew; S B Whiting
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

Review 9.  Evidence for more than one type of post-junctional alpha-adrenoceptor.

Authors:  J C McGrath
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

10.  Presence of postsynaptic alpha 2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb.

Authors:  S Z Langer; R Massingham; N B Shepperson
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

View more
  17 in total

1.  Influence of angiotensin II on the alpha-adrenoceptors involved in mediating the response to sympathetic nerve stimulation in the rabbit isolated distal saphenous artery.

Authors:  W R Dunn; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.

Authors:  J M Allen; J G McCarron; N G McHale; K D Thornbury
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  An examination of 5-hydroxytryptamine receptors in human saphenous vein.

Authors:  J R Docherty; L Hyland
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

4.  "First-dose" response to mianserin: effects of age.

Authors:  C G Swift; M R Swift; B Tiplady
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors.

Authors:  S Connaughton; J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

6.  No evidence for differences between pre- and post-junctional alpha 2-adrenoceptors.

Authors:  J R Docherty; L Hyland
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

7.  Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

Authors:  H Racchi; M J Irarrázabal; M Howard; S Morán; R Zalaquett; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

8.  Frequency- and train length-dependent variation in the roles of postjunctional alpha 1- and alpha 2-adrenoceptors for the field stimulation-induced neurogenic contraction of rat tail artery.

Authors:  J X Bao; F Gonon; L Stjärne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

9.  Influences of the endothelium and hypoxia on neurogenic transmission in the isolated pulmonary artery of the rabbit.

Authors:  M R MacLean; K M McCulloch; J B MacMillan; J C McGrath
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

10.  Involvement of alpha 1- and alpha 2-adrenoceptors in the responses of proximal and distal segments of the canine saphenous vein to exogenous and endogenous noradrenaline.

Authors:  O Pereira; D Moura; P Nunes; M J Vaz-da Silva; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.